Mix-and-Match COVID Vaccines Trigger Potent Immune Response

Trouble viewing? View in your browser.
View all Scientific American publications.
    
May 21, 2021

Medicine

Mix-and-Match COVID Vaccines Trigger Potent Immune Response

Preliminary results from a trial of more than 600 people are the first to show the benefits of combining different vaccines

By Ewen Callaway,Nature magazine

Climate

'Whitest White' Paint Beats the Heat

A new nanomaterial mixture lets surfaces release more heat than they absorb

By Sophie Bushwick

Climate

Biden Executive Order Targets Climate Financial Risks

The directive charges federal agencies with assessing the potential economic toll of warming and urging regulators to it

By Avery Ellfeldt,E&E News

Conservation

Cuba's Economic Isolation Protected Its Environment

The island nation has fewer nonnative plants than other Caribbean islands

By Meghan Brown,Jeffrey Corbin

Public Health

COVID, Quickly, Episode 7: The Coming Pandemic Grief Wave, and Mask Whiplash

Today we bring you a new episode in our podcast series: COVID, Quickly. Every two weeks, Scientific American's senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.

By Josh Fischman,Tanya Lewis,Jeffery DelViscio | 07:03

Cognition

You Don't Have to Start Young to Be a Great Musician

A new study refutes the idea that there is a critical learning period in childhood

By Cindi May

Public Health

Coronavirus News Roundup, May 8–May 21

Pandemic highlights for the past two weeks

By Robin Lloyd

Public Health

Math and Sleuthing Help to Explain Epidemics of the Past

One mathematician has spend decades uncovering the deadly calculations of pestilence and plague, sometimes finding data that were hiding in plain sight.

By Emily Schwing | 07:30

EARTH

World's Largest Iceberg Breaks Off of Antarctica

The chunk of ice is larger than the state of Rhode Island

By Ben Turner,LiveScience

Wellness

The Global Iron-Deficiency Crisis

Some two billion people don't get enough of this essential mineral in their diets

By Sharman Apt Russell
FROM THE STORE

ADVERTISEMENT

FROM THE ARCHIVE

Delaying a COVID Vaccine's Second Dose Boosts Immune Response in the Elderly

People older than 80 who waited 11 to 12 weeks for their second jab had higher peak antibody levels than did those who waited only three weeks

QUOTE OF THE DAY

"I do think there's a brave new world of vaccinology to be scoped in all of this."

Daniel Altmann, immunologist at Imperial College London

LATEST ISSUES

Questions?   Comments?

Send Us Your Feedback
Download the Scientific American App
Download on the App Store
Download on Google Play

To view this email as a web page, go here.

You received this email because you opted-in to receive email from Scientific American.

To ensure delivery please add news@email.scientificamerican.com to your address book.

Unsubscribe     Manage Email Preferences     Privacy Policy     Contact Us

Comments

Popular Posts